Cancer mortality trends in the EU and acceding countries up to 2015

Mike J. Quinn, A. d'Onofrio, B. Møller, R. Black, C. Martinez-Garcia, H. Møller, M. Rahu, C. Robertson, L. J. Schouten, C. La Vecchia, P. Boyle

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Background: Examination of trends in cancer mortality in Europe over the past 30 years has shown that, after long-term rises, age-standardised mortality from most common cancer sites has fallen in the EU since the late 1980s. This study aimed to examine trends in the age-specific and age-standardised cancer mortality rates and numbers of cancer deaths up to 2020 for all cancers and various specific sites for all 15 EU countries, the 10 acceding countries, Bulgaria and Romania (currently applicant countries, along with Turkey), and Iceland, Norway and Switzerland of the four EEA countries. Patients and methods: Mortality rates were modelled as a function of age, calendar period and birth cohort. Birth cohort was calculated as age subtracted from calendar period. Results: As a consequence of the generally decreasing trends in the age-standardised rates, the best estimate is that there will be ∼1.25 million cancer deaths in 2015, which is almost 130000 (11%) more deaths than in 2000, but 155000 (11%) fewer deaths than the 1.4 million projected in 2015 on the basis of demographic changes alone. The increases in the forecast numbers of cancer deaths in 2015 are proportionally larger in males than in females (13% and 10%, respectively) and proportionally larger in the acceding countries than in the current EU member countries (14% and 11%, respectively). Conclusions: Our forecasts are conservative best estimates of future cancer mortality. There is clearly scope for large improvements in survival, and hence reductions in cancer mortality, in some countries, through eliminating these differences using existing knowledge and treatment regimes.

Original languageEnglish
Pages (from-to)1148-1152
Number of pages5
JournalAnnals of Oncology
Volume14
Issue number7
DOIs
Publication statusPublished - Jul 1 2003

Fingerprint

Mortality
Neoplasms
Parturition
Iceland
Bulgaria
Romania
Norway
Turkey
Switzerland
Demography
Survival
Calendars
Therapeutics

Keywords

  • Cancer
  • Europe
  • Forecasts
  • Mortality
  • Trends

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Quinn, M. J., d'Onofrio, A., Møller, B., Black, R., Martinez-Garcia, C., Møller, H., ... Boyle, P. (2003). Cancer mortality trends in the EU and acceding countries up to 2015. Annals of Oncology, 14(7), 1148-1152. https://doi.org/10.1093/annonc/mdg307

Cancer mortality trends in the EU and acceding countries up to 2015. / Quinn, Mike J.; d'Onofrio, A.; Møller, B.; Black, R.; Martinez-Garcia, C.; Møller, H.; Rahu, M.; Robertson, C.; Schouten, L. J.; La Vecchia, C.; Boyle, P.

In: Annals of Oncology, Vol. 14, No. 7, 01.07.2003, p. 1148-1152.

Research output: Contribution to journalArticle

Quinn, MJ, d'Onofrio, A, Møller, B, Black, R, Martinez-Garcia, C, Møller, H, Rahu, M, Robertson, C, Schouten, LJ, La Vecchia, C & Boyle, P 2003, 'Cancer mortality trends in the EU and acceding countries up to 2015', Annals of Oncology, vol. 14, no. 7, pp. 1148-1152. https://doi.org/10.1093/annonc/mdg307
Quinn MJ, d'Onofrio A, Møller B, Black R, Martinez-Garcia C, Møller H et al. Cancer mortality trends in the EU and acceding countries up to 2015. Annals of Oncology. 2003 Jul 1;14(7):1148-1152. https://doi.org/10.1093/annonc/mdg307
Quinn, Mike J. ; d'Onofrio, A. ; Møller, B. ; Black, R. ; Martinez-Garcia, C. ; Møller, H. ; Rahu, M. ; Robertson, C. ; Schouten, L. J. ; La Vecchia, C. ; Boyle, P. / Cancer mortality trends in the EU and acceding countries up to 2015. In: Annals of Oncology. 2003 ; Vol. 14, No. 7. pp. 1148-1152.
@article{e3c05f8363694511b1ddf65025e41376,
title = "Cancer mortality trends in the EU and acceding countries up to 2015",
abstract = "Background: Examination of trends in cancer mortality in Europe over the past 30 years has shown that, after long-term rises, age-standardised mortality from most common cancer sites has fallen in the EU since the late 1980s. This study aimed to examine trends in the age-specific and age-standardised cancer mortality rates and numbers of cancer deaths up to 2020 for all cancers and various specific sites for all 15 EU countries, the 10 acceding countries, Bulgaria and Romania (currently applicant countries, along with Turkey), and Iceland, Norway and Switzerland of the four EEA countries. Patients and methods: Mortality rates were modelled as a function of age, calendar period and birth cohort. Birth cohort was calculated as age subtracted from calendar period. Results: As a consequence of the generally decreasing trends in the age-standardised rates, the best estimate is that there will be ∼1.25 million cancer deaths in 2015, which is almost 130000 (11{\%}) more deaths than in 2000, but 155000 (11{\%}) fewer deaths than the 1.4 million projected in 2015 on the basis of demographic changes alone. The increases in the forecast numbers of cancer deaths in 2015 are proportionally larger in males than in females (13{\%} and 10{\%}, respectively) and proportionally larger in the acceding countries than in the current EU member countries (14{\%} and 11{\%}, respectively). Conclusions: Our forecasts are conservative best estimates of future cancer mortality. There is clearly scope for large improvements in survival, and hence reductions in cancer mortality, in some countries, through eliminating these differences using existing knowledge and treatment regimes.",
keywords = "Cancer, Europe, Forecasts, Mortality, Trends",
author = "Quinn, {Mike J.} and A. d'Onofrio and B. M{\o}ller and R. Black and C. Martinez-Garcia and H. M{\o}ller and M. Rahu and C. Robertson and Schouten, {L. J.} and {La Vecchia}, C. and P. Boyle",
year = "2003",
month = "7",
day = "1",
doi = "10.1093/annonc/mdg307",
language = "English",
volume = "14",
pages = "1148--1152",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Cancer mortality trends in the EU and acceding countries up to 2015

AU - Quinn, Mike J.

AU - d'Onofrio, A.

AU - Møller, B.

AU - Black, R.

AU - Martinez-Garcia, C.

AU - Møller, H.

AU - Rahu, M.

AU - Robertson, C.

AU - Schouten, L. J.

AU - La Vecchia, C.

AU - Boyle, P.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: Examination of trends in cancer mortality in Europe over the past 30 years has shown that, after long-term rises, age-standardised mortality from most common cancer sites has fallen in the EU since the late 1980s. This study aimed to examine trends in the age-specific and age-standardised cancer mortality rates and numbers of cancer deaths up to 2020 for all cancers and various specific sites for all 15 EU countries, the 10 acceding countries, Bulgaria and Romania (currently applicant countries, along with Turkey), and Iceland, Norway and Switzerland of the four EEA countries. Patients and methods: Mortality rates were modelled as a function of age, calendar period and birth cohort. Birth cohort was calculated as age subtracted from calendar period. Results: As a consequence of the generally decreasing trends in the age-standardised rates, the best estimate is that there will be ∼1.25 million cancer deaths in 2015, which is almost 130000 (11%) more deaths than in 2000, but 155000 (11%) fewer deaths than the 1.4 million projected in 2015 on the basis of demographic changes alone. The increases in the forecast numbers of cancer deaths in 2015 are proportionally larger in males than in females (13% and 10%, respectively) and proportionally larger in the acceding countries than in the current EU member countries (14% and 11%, respectively). Conclusions: Our forecasts are conservative best estimates of future cancer mortality. There is clearly scope for large improvements in survival, and hence reductions in cancer mortality, in some countries, through eliminating these differences using existing knowledge and treatment regimes.

AB - Background: Examination of trends in cancer mortality in Europe over the past 30 years has shown that, after long-term rises, age-standardised mortality from most common cancer sites has fallen in the EU since the late 1980s. This study aimed to examine trends in the age-specific and age-standardised cancer mortality rates and numbers of cancer deaths up to 2020 for all cancers and various specific sites for all 15 EU countries, the 10 acceding countries, Bulgaria and Romania (currently applicant countries, along with Turkey), and Iceland, Norway and Switzerland of the four EEA countries. Patients and methods: Mortality rates were modelled as a function of age, calendar period and birth cohort. Birth cohort was calculated as age subtracted from calendar period. Results: As a consequence of the generally decreasing trends in the age-standardised rates, the best estimate is that there will be ∼1.25 million cancer deaths in 2015, which is almost 130000 (11%) more deaths than in 2000, but 155000 (11%) fewer deaths than the 1.4 million projected in 2015 on the basis of demographic changes alone. The increases in the forecast numbers of cancer deaths in 2015 are proportionally larger in males than in females (13% and 10%, respectively) and proportionally larger in the acceding countries than in the current EU member countries (14% and 11%, respectively). Conclusions: Our forecasts are conservative best estimates of future cancer mortality. There is clearly scope for large improvements in survival, and hence reductions in cancer mortality, in some countries, through eliminating these differences using existing knowledge and treatment regimes.

KW - Cancer

KW - Europe

KW - Forecasts

KW - Mortality

KW - Trends

UR - http://www.scopus.com/inward/record.url?scp=0041853712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041853712&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg307

DO - 10.1093/annonc/mdg307

M3 - Article

C2 - 12853360

AN - SCOPUS:0041853712

VL - 14

SP - 1148

EP - 1152

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 7

ER -